Publication | Closed Access

Chipping at large, potent human T-cell leukemia virus type 1 protease inhibitors to uncover smaller, equipotent inhibitors

Protease InhibitorsHuman RetrovirusImmunologyEquipotent InhibitorsAntiviral ResponseVirologyAntiviral Drug DevelopmentAntiviral DrugHivImmunotherapyMedicineAdult T-cell Leukemia-lymphomaBiomolecular EngineeringDrug Discovery